• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/34

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

34 Cards in this Set

  • Front
  • Back
Opioid Receptors
G Protein Coupled Receptors
Inhibit adenylyl cyclase
Activate K currents post-synaptically
Inhibit Ca currents pre-synaptically
Opioid Receptor Subtypes
MOP-analgesia & majority of opioid effects
DOP-analgesia
KOP- analgesia or antianalgesia (inhibits MOP)
NOP- analgesia effects inconclusive
Nociceptive C Fibers
Unmyelinated
Transmit slow, dull pain
Nociceptor
Thermoreceptor
Mechanoreceptor
Nociceptive Ad Fibers
Transmit sharp, prickly pain
Nociceptor
Mechanoreceptor
Indirect Pathway of Opioid Action
Opioid receptors (in the PAG, Reticular formation, median raphe, nucleus raphe magnus, gigantocellular reticular nucleus, rostral ventromedial medulla) are activated and cause inhibition of GABA such that the pain control circuits in the descending pathway are modified and more opioid activity occurs in the SC
Direct Action of Opioid Receptors
Direct inhibition of ascending transmission of nociceptive information from the SC dorsal horn
Opioid agonist effects
Analgesia
Respiratory Despression
Miosis
Euphoria
Sedation
Cough
Nausea and Vomiting
Vascular (Orthostatic Hypotension)
Constipation
Histamine release
Effects of opioids that exhibit little or no tolerance
Miosis, Convulsions, Constipation
Opioids affected by CYP2D6 Polymorphisms
Codeine, Hydrocodone, and Oxycodone
Morphine
Half life: 2 hrs
Hydrophilic so doesn't cross BBB as readily
25% Bioavailability
Metabolite Morphine-3-Gluc (90%) has excitatory effects
Metabolite Morphine-6-Gluc has inhibitory effects more potent than morphine
Meperidine
Half life: 3 hrs
52% Bioavailability
Produces same side effects as morphine at equianalgesic doses except it has less urinary retention and constipation
Metabolite normeperidine has half life of 15-20hrs and can cause CNS excitation
Methadone
Half life: 15-40hrs
92% bioavailable
90% bound to plasma proteins
Equianalgesic effects to morphine as well as side effects
Also blocks NMDA receptors and monoaminergic reuptake
Treats chronic pain, opioid addicts and opioid abstinence syndrome
Fentanyl
Alfentanil
Sufentanil
Remifentanil
Synthetic MOP agonists
Highly lipid soluble
Faster onset than morphine and more rapid respiratory depression
Potency greater than morphine
Remifentanil is metabolized by plasma esterases
Fentanyl and Sufentanil- surgical pain mgmt
Alfentanil and Remifentanil- short painful procedures
Levorphanol
Synthetic opioid
Comparable to morphine for analgesia
Less nausea and vomiting than morphine
Heroin
Given IM is 2x more potent than morphine
Metabolized to 6-MAM and morphine
All are lipid soluble
Excreted as free and conjugated morphine
Codeine
Partial agonist
50% bioavailable
10% is metabolized to morphine
Used for mod. pain and as an antitussive
Combined with Aspirin or Acetaminophen to increase analgesia
Active metabolites
Propoxyphene
1/2-1/3 as effective as codeine
Combined with acetominophen or aspirin
Norpropoxyphene is a toxic metabolite
Tramadol
Synthetic Codeine analog
Weak agonist
Also inhibits Ser and NE uptake
Less constipation than codeine and no effects on respiration or CV
Active metabolite lends risk for CNS overexcitation
Opioids with active metabolites
Morphine
Heroin
Codeine
Naltrexone
Opioids with excitatory/toxic metabolites
Morphine
Meperidine
Propoxyphene
Tramadol
Nalbuphine
Agonist at KOP and antagonist of MOP
10mg is equianalgesic to 10mg morphine
Psychomimetic at high doeses
Analgesia and Resp depression at 30mg
Precipitates withdrawl in patients on low opioid doses
Pentazocine
Agonist at KOP, MOP agonist/antagonist
Like Nalbuphine (Ceiling effects, resp. depression) but also has effect on cardiac system
Precipitates withdrawl in MOP agonist dependent person
Doesn't antagonize morphine induced resp. depression
Psychomimetic at high doses
Buprenorphine
MOP partial agonist (High binding affinity but low intrinsic activity)
KOP and DOP antagonist
Resp depression is preventable with prior opioid antag
Antagonizes resp dep of Fentanyl because of binding affinity
As effective as methadone in Detox
Butorphanol
KOP agonist, MOP antagonist/partial agonist
Analgesic doses increase pulmonary arterial pressure and cardiac work
Dextromethorphan
Antitussive
Doesn't act through opioid receptor: an NMDA antagonist
Fewer SEs than codeine
High doses may cause CNS depression
Loperimide
Meperidine derivative for antidiarrhea
Slows GI motility
Doesn't cross BBB
No pleasurable effects at high doses
Diphenoxylate
Meperidine derivative only used for treating diarrhea
Typical opioid activity at high doses
Opioid Antagonists
Naloxone
Nalmefene
Naltrexone
Interact at MOP, KOP and DOP but greatest activity at MOP
Produce few effects in people not on agonists
Naloxone
Half life of 1 hr. and almost totally metabolized by liver so given IV
Rapid onset and short duration of action
Nalmefene
Half life 8-10 hrs
More potent than naloxone and 40% bioavailable
Naltrexone
More potent than naloxone
Metabolite 6-naltrexol is a weaker antagonist
Efficacy is maintained with oral admin.
Approved to treat alcoholism
Acute Opioid Toxicity
Triad of coma, miosis, respiratory depression
Naloxone is treatment of choice for acute toxicity (It's duration of action is shorter than most opioids so monitor continuously)
Opioid Antagonists effects for different patients
Morphine treated patient- reverse effect
Acutely depressed patient- normalized
Opioid Dependent patient- Abstinence syndrome induced
Opioid naiive person- no effects
Contraindications
Impaired respiratory fx, Hepatic disease, Renal disease, Asthmatics (could give fentanyl), pregnant, head injuries (resp depression causes vasodilation), Patients with decreased blood volume, patients on MAO inhibitors